Bio-Rad Laboratories (BIO) Long-Term Investments (2012 - 2026)
Bio-Rad Laboratories (BIO) reported Long-Term Investments of $5.3 billion for Q1 2026, up 6.36% year-over-year from $5.0 billion in Q1 2025, and down 12.97% on a QoQ basis from $6.1 billion in Q4 2025.
Bio-Rad Laboratories (BIO) has 15 years of Long-Term Investments data on file, last reported at $5.3 billion in Q1 2026.
- Quarterly Long-Term Investments rose 6.36% year-over-year to $5.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.3 billion (up 6.36% YoY) and the FY2025 annual result came in at $6.1 billion, up 26.13% from the prior year.
- Long-Term Investments retreated to $5.3 billion in Q1 2026 per BIO's latest filing, from $6.1 billion in the prior quarter.
- Across five years, Long-Term Investments topped out at $9.7 billion in Q1 2022 and bottomed at $4.8 billion in Q4 2024.
- The 5-year median for Long-Term Investments is $7.2 billion (2023), against an average of $6.8 billion.
- The widest annual swing landed in 2022, when Long-Term Investments slumped 54.04%; it then rose 26.13% in 2025.
- Tracing BIO's Long-Term Investments over 5 years: stood at $8.8 billion in 2022, then slipped by 12.83% to $7.7 billion in 2023, then sank by 37.14% to $4.8 billion in 2024, then rose by 26.13% to $6.1 billion in 2025, then decreased by 12.97% to $5.3 billion in 2026.
- Per Business Quant, the three latest BIO Long-Term Investments figures stand at $5.3 billion (Q1 2026), $6.1 billion (Q4 2025), and $5.1 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 166.25 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn | 5.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.31 Bn |
| Dec 31, 2025 | 6.10 Bn |
| Sep 30, 2025 | 5.06 Bn |
| Jun 30, 2025 | 5.58 Bn |
| Mar 31, 2025 | 4.99 Bn |
| Dec 31, 2024 | 4.84 Bn |
| Sep 30, 2024 | 6.00 Bn |
| Jun 30, 2024 | 5.10 Bn |
| Mar 31, 2024 | 8.02 Bn |
| Dec 31, 2023 | 7.70 Bn |
| Sep 30, 2023 | 7.22 Bn |
| Jun 30, 2023 | 7.31 Bn |
| Mar 31, 2023 | 8.88 Bn |
| Dec 31, 2022 | 8.83 Bn |
| Sep 30, 2022 | 7.46 Bn |
| Jun 30, 2022 | 8.09 Bn |
| Mar 31, 2022 | 9.69 Bn |
| Dec 31, 2021 | 14.39 Bn |
| Sep 30, 2021 | 16.23 Bn |
| Jun 30, 2021 | 11.58 Bn |
| Mar 31, 2021 | 10.50 Bn |
| Dec 31, 2020 | 9.56 Bn |
| Sep 30, 2020 | 8.44 Bn |
| Jun 30, 2020 | 6.70 Bn |
| Mar 31, 2020 | 5.43 Bn |
| Dec 31, 2019 | 4.64 Bn |
| Sep 30, 2019 | 3.93 Bn |
| Jun 30, 2019 | 4.42 Bn |
| Mar 31, 2019 | 3.67 Bn |
| Dec 31, 2018 | 2.66 Bn |
| Sep 30, 2018 | 3.47 Bn |
| Jun 30, 2018 | 3.17 Bn |
| Mar 31, 2018 | 2.98 Bn |
| Dec 31, 2017 | 1.03 Bn |
| Sep 30, 2017 | 1.03 Bn |
| Jun 30, 2017 | 1.04 Bn |
| Mar 31, 2017 | 955.62 Mn |
| Dec 31, 2016 | 830.79 Mn |
| Sep 30, 2016 | 903.66 Mn |
| Jun 30, 2016 | 810.46 Mn |
| Mar 31, 2016 | 711.44 Mn |
| Dec 31, 2015 | 719.84 Mn |
| Sep 30, 2015 | 663.53 Mn |
| Jun 30, 2015 | 541.73 Mn |
| Mar 31, 2015 | 400.26 Mn |
| Dec 31, 2014 | 389.31 Mn |
| Sep 30, 2014 | 364.13 Mn |
| Jun 30, 2014 | 382.91 Mn |
| Mar 31, 2014 | 420.24 Mn |
| Dec 31, 2013 | 377.87 Mn |
| Sep 30, 2013 | 354.73 Mn |
| Dec 31, 2012 | 293.61 Mn |